Aminologics Co.Ltd Cash Flow Conversion Efficiency
Aminologics Co.Ltd cash flow conversion efficiency. Based on the latest financial reports, Aminologics Co.Ltd (074430) has a cash flow conversion efficiency ratio of -0.004x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-255.72 Million ≈ $-173.30K USD) by net assets (₩58.43 Billion ≈ $39.60 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Aminologics Co.Ltd (2008–2025)
Cash flow conversion efficiency of Aminologics Co.Ltd from 2008 to 2025. This chart illustrates how Aminologics Co.Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View current stock price of Aminologics Co.Ltd for real-time trading data and today's change.
Aminologics Co.Ltd Cash Flow Conversion Ratio Explained
Aminologics Co.Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Aminologics Co.Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Aminologics Co.Ltd ranked by their cash flow conversion efficiency. Also see 074430 market cap for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Kaulin Mfg
TW:1531
|
0.024x |
|
Powerlogics Co. Ltd
KQ:047310
|
-0.024x |
|
Gagasan Nadi Cergas Berhad
KLSE:0206
|
0.242x |
|
Aquila European Renewables Income PLC
LSE:AERI
|
0.005x |
|
Kanpur Plastipack Limited
NSE:KANPRPLA
|
0.057x |
|
Solutions 30 SE
F:30L3
|
-0.234x |
|
Jaiprakash Associates Limited
NSE:JPASSOCIAT
|
0.065x |
|
Arn Media Ltd
AU:A1N
|
0.128x |
Annual Cash Flow Conversion Efficiency for Aminologics Co.Ltd (2008–2025)
The table below shows the annual cash flow conversion efficiency of Aminologics Co.Ltd from 2008 to 2025. Review 074430 free cash flow to operating cash ratio to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | ₩55.99 Billion ≈ $37.95 Million |
₩2.54 Billion ≈ $1.72 Million |
0.045x | -68.58% |
| 2024-12-31 | ₩51.70 Billion ≈ $35.03 Million |
₩7.47 Billion ≈ $5.06 Million |
0.144x | +3702.19% |
| 2023-12-31 | ₩54.41 Billion ≈ $36.87 Million |
₩-218.15 Million ≈ $-147.84K |
-0.004x | -103.94% |
| 2022-12-31 | ₩51.40 Billion ≈ $34.84 Million |
₩5.23 Billion ≈ $3.54 Million |
0.102x | +545.46% |
| 2021-12-31 | ₩59.39 Billion ≈ $40.25 Million |
₩935.52 Million ≈ $633.99K |
0.016x | -52.29% |
| 2020-12-31 | ₩53.56 Billion ≈ $36.30 Million |
₩1.77 Billion ≈ $1.20 Million |
0.033x | -52.50% |
| 2019-12-31 | ₩51.85 Billion ≈ $35.14 Million |
₩3.60 Billion ≈ $2.44 Million |
0.070x | -18.90% |
| 2018-12-31 | ₩53.19 Billion ≈ $36.04 Million |
₩4.56 Billion ≈ $3.09 Million |
0.086x | +28.94% |
| 2017-12-31 | ₩45.14 Billion ≈ $30.59 Million |
₩3.00 Billion ≈ $2.03 Million |
0.066x | -28.45% |
| 2016-12-31 | ₩44.55 Billion ≈ $30.19 Million |
₩4.14 Billion ≈ $2.80 Million |
0.093x | +132.53% |
| 2015-12-31 | ₩48.28 Billion ≈ $32.72 Million |
₩1.93 Billion ≈ $1.31 Million |
0.040x | +161.59% |
| 2014-12-31 | ₩31.85 Billion ≈ $21.58 Million |
₩-2.07 Billion ≈ $-1.40 Million |
-0.065x | -127.90% |
| 2008-12-31 | ₩52.44 Billion ≈ $35.54 Million |
₩12.19 Billion ≈ $8.26 Million |
0.233x | -- |
About Aminologics Co.Ltd
Aminologics Co.,Ltd., a specialty amino acid provider, develops a range of amino-acid-based raw materials for pharmaceutical and fine chemical industries in South Korea. Its products include D-phenylalanine, D-alanine, D-cysteine, D-serine, D-allo-isoleucine, D-allo-threonine, S-beta-phenylalanine, 3-(2-napthyl)-D-alanine, 4-chloro-D-phenylalanine, 3-(2-napthyl)-L-alanine, R-beta-phenylalanine, D… Read more